← Leaderboards
Maryl R. Johnson
Northwestern University
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Lewis J Smith$3,354,428
- Daniel Batlle$5,645,633
- Debiao Li$36,112,049
- Mary McGrae McDermott$74,643,817
- Vadim Backman$34,873,053
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAngiotensin ReceptorAntihypertensive AgentsAzithromycinCardiovascular Disorder ChemotherapyChlamydiaceaeChlamydial DiseaseChronic Disease /DisorderCombination ChemotherapyCongestive Heart FailureCoronary DisorderHeart Disorder ChemotherapyHuman Therapy EvaluationInhibitor /AntagonistMyocardial InfarctionOutcomes ResearchPlacebosAce InhibitorsQuality Of LifeAngiotensin Ii
Grant awards (4)
EFFECT OF VALSARTAN IN PATIENTS WITH STABLE, CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2001 · RR
AZITHROMYCIN AND CORONARY EVENTS STUDY (ACES)$0
M01 · FY2001 · RR
EFFECT OF VALSARTAN IN PATIENTS WITH STABLE, CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2000 · RR
AZITHROMYCIN AND CORONARY EVENTS STUDY (ACES)$0
M01 · FY2000 · RR